Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers

Purpose: To demonstrate the safety and feasibility of leveraging therapeutic antibodies for surgical imaging. Procedures: We conducted two phase I trials for anti-epidermal growth factor receptor antibodies cetuximab-IRDye800CW (n=12) and panitumumab-IRDye800CW (n=15). Adults with biopsy-confirmed h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Gao, Rebecca W., Teraphongphom, Nutte, de Boer, Esther, van den Berg, Nynke S., Divi, Vasu, Kaplan, Michael J., Oberhelman, Nicholas J., Hong, Steven S., Capes, Elissa, Colevas, A. Dimitrios, Warram, Jason M., Rosenthal, Eben L.
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928904/
https://ncbi.nlm.nih.gov/pubmed/29721094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.24487
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados